Jul 26, 2019 / 01:00AM GMT
Presentation
Jul 26, 2019 / 01:00AM GMT
=====================
Corporate Participants
=====================
* Osamu Okuda
Chugai Pharmaceutical Co., Ltd. - Executive VP and Co-Head of Project, Lifecycle Management Unit & Foundation Medicine
* Tatsuro Kosaka
Chugai Pharmaceutical Co., Ltd. - President, CEO & Representative Director
* Toshiaki Itagaki
Chugai Pharmaceutical Co., Ltd. - EVP, CFO and GM of Finance Supervisory Division, Finance & Accounting Dept.
* Yasushi Ito
Chugai Pharmaceutical Co., Ltd. - Executive VP and Co-Head of Project & Lifecycle Management Unit
=====================
Conference Call Participants
=====================
* Fumiyoshi Sakai
Crédit Suisse AG, Research Division - Research Analyst
* Hidemaru Yamaguchi
Citigroup Inc, Research Division - MD and Analyst
* Kazuaki Hashiguchi
Daiwa Securities Co. Ltd., Research Division - Research Analyst
* Seiji Wakao
Mitsubishi UFJ Morgan Stanley Securities Co., Ltd., Research Division -
Chugai Pharmaceutical Co Ltd
(STU:CUP)
€
36.79
-2.08 (-5.35%)
Market Cap: 61.80 Bil
Enterprise Value: 56.59 Bil
PE Ratio: 24.20
PB Ratio: 5.63
GF Score: 95/100 Q2 2019 Chugai Pharmaceutical Co Ltd Earnings Presentation Transcript
Jul 26, 2019 / 01:00AM GMT
Release Date Price:
€20.98
(+6.48%)
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
7-Day Free Trial · Cancel Anytime
Subscription fee may be tax deductible.
Excellent 

4.6 out of 5
Trustpilot